© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Based on recent data, Capricor Therapeutics, Inc. (CAPR) shows an Average True Range (ATR) of 2.55 and an Enterprise Value of 149.69M. Its average trading volume over the past 3 months is 2.83M, indicating liquidity. These fundamental metrics provide insight into CAPR's underlying financial health and market activity.
Capricor Therapeutics, Inc. (CAPR) technical indicators as of December 23, 2025: the SMA 20 is 42.14%, SMA 50 at 146.24%, and SMA 200 at 197.01%. The RSI 14 value is 75.03, suggesting its current momentum. These technical analysis signals help assess CAPR's price trends and potential future movements.
Capricor Therapeutics, Inc. (CAPR) stock performance overview as of December 23, 2025: The 52-week high is $40.37 (currently -26.93% below), and the 52-week low is $4.3 (currently 586.05% above). Over the past year, CAPR's performance is 112.54%, compared to the S&P 500's 10.56% change.
According to market data, Capricor Therapeutics, Inc. (CAPR) stock's recent performance metrics show that over the last month, CAPR is 411.27%, with a Year-to-Date (YTD) performance of 113.77%. Over the past year, the stock has seen a 112.54% change. These figures summarize CAPR's price movements across various periods, reflecting its historical returns.
According to current financial data, CAPR stock's P/E (TTM) ratio is -18.82, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.24. Key valuation ratios for CAPR, including P/S (98.36), P/B (12.55), and P/FCF (-23.37), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.